Food and Drug Administration (FDA) is the competent authority designated by the current federal law (Tobacco Control Act) for the application of the new regulation.

FDA regulation of the ENDS is still a process in progress. FDA has already estimated ways, times and costs for the marketing authorization process, but the indications given could be revised.

To date, in fact, FDA indicates 6 obligations to be followed:

The deadlines indicated in this timeline refer to products already on the market as of August 8, 2016 marketed by small-scale producers/importers (up to 150 full-time or equivalent employees and up to total revenues of $5,000,000). FDA regulation provides for different deadlines depending on the marketing date and the size of the company producing or distributing: below you can find more details.

FDA requires a procedure which provides the administrative and personal data of the establishments that produce or process ENDS in the US, and the complete list of products.

Deadlines:

Have your products been placed on the US market before August 8th 2016? Have you already done the communication of the data required by this step? If you need assistance, contact us.

It’s a dossier containing information on the toxicology and on the health effects of the finished products and their constituents.

Currently FDA requires the health documents drawn up between June 23rd 2009 and December 31st 2009. The documents drawn up at successive times must be kept available for future requests.

Deadlines:

If you have not provided for the creation of this dossier and you are looking for someone to support you, contact us: we will put our expertise at your service.

FDA expects producers and importers to send a document with the complete list, for each product, of all the ingredients present, including compounds and additives, quantities and related functions.

Deadlines:

Also thanks to the experience developed in the eruopean regulation TPD-II, we know how to optimize such a complex work: call us to find out more.

Starting from August 10, 2018 new requirements for labeling has come into force; the distribution of products with non-compliant packaging is no longer allowed.

Deadlines:

Are your products compliant with the new requirements for product labeling? Our regulatory experts are at your disposal to give you more detailed information.

The current regulations requires a dossier that provides, for each product, the quantities of substances identified as harmful or potentially harmful to health (HPHC).
The guidelines for researching and quantifying HPHCs in ENDS are currently being defined by FDA.

Deadlines:

Gathering information on the toxicity of the substances present in every product on the market is a long and highly responsible process: if you are looking for someone who has the tools to help you proceed in this aspect, contact us.

To be placed legally on the market, a vaping product must obtain an authorization from FDA, which will be issued on the basis of the evaluation of a dossier in which the product and each component is described in terms of quality and safety.

Deadlines:

PMTA is a document of fundamental importance, the preparation of which is very demanding. It is therefore important to begin to know the information requested, and to check if they are available or not in relation to your products.

Contact us for more information.